Navigation Links
Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe
Date:6/24/2011

rnett, clinical director, Department of Diabetes and Endocrinology, University of Birmingham and Heart of England NHS, UK. "Of note, linagliptin is primarily excreted via the bile and gut, meaning no dose adjustment is recommended in patients with kidney or liver impairment. Therefore, this will be the first DPP-4 inhibitor available at one dose for all adult patients with type 2 diabetes."

Linagliptin received a positive opinion based on a clinical trial program which involved approximately 4,000 adults with type 2 diabetes. Included in the program were placebo-controlled studies evaluating linagliptin as monotherapy and in combination with the commonly prescribed oral antihyperglycemic medications, metformin and/or sulfonylurea.  In two monotherapy studies, linagliptin showed a statistically significant mean difference in A1C from placebo of -0.6 to -0.7 percent. In patients who were not adequately controlled on metformin or metformin plus sulfonylurea, the addition of linagliptin also resulted in a statistically significant mean difference in A1C from placebo of -0.6 percent.

"Type 2 diabetes is increasing at an alarming rate worldwide. We are proud that we may soon have the opportunity to offer a new treatment option from our own Boehringer Ingelheim research labs to the millions of European patients with type 2 diabetes whose blood glucose is not adequately controlled," said Prof. Klaus Dugi, corporate senior vice president medicine, Boehringer Ingelheim.

The CHMP positive opinion for linagliptin marks another regulatory milestone for the Boehringer Ingelheim and Eli Lilly and Company worldwide diabetes alliance, which was formed in January 2011. Linagliptin received approval for use in the U.S. in May 2011.

"We are extremely pleased by the CHMP positive recommendation for approval of linagliptin in Europe," said Enrique Conterno, president of Lilly Diabetes. "Based on our comprehensive studies and the CHMP's positive r
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
2. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
3. Catheterization Recommended for Treating Pediatric Heart Conditions
4. BYDUREON™ Recommended for Approval in Europe
5. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
6. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
7. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
8. Half of All Women Do Not Get Regular Mammograms Despite Recommended Guidelines
9. Encisions Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress
10. DaTSCAN™ (Ioflupane I 123 Injection) Recommended in Updated European Guidelines for Diagnosis of Alzheimers Disease
11. Alaska EHR Alliance Selects e-MDs as Recommended Electronic Health Record Vendor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  The North Shore-LIJ Health System is ... hand-washing compliance at North Shore University Hospital in ... operating rooms at Forest Hills ... The new pilot program strengthens patient safety by ... (ORs), the first time in the US that remote ...
(Date:5/21/2013)... May 21, 2013   Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...
(Date:5/21/2013)... ST. LOUIS , May 21, 2013 ... to treat chronic, complex diseases such as cancer, multiple ... 67 percent by the end of 2015, according to ... (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ) ... time for employers and health plans to act so ...
Breaking Medicine Technology:North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5
(Date:5/21/2013)... drugs which lower intraocular pressure, are often the first ... use is not without risks. PGAs have long been ... and other side effects. Now a new study has ... eyelid drooping and other issues that can interfere with ... . , Researchers from the Massachusetts Eye and Ear ...
(Date:5/21/2013)... 21, 2013 HealthSmart continues to grow ... presence has required the hiring of new talent in ... pleased to announce that Dawn Powell has joined the ... the Director of Account Management in the Central Region ... Irving, Texas. With extensive client management, employee benefits, and ...
(Date:5/21/2013)... Arizona State University is seeking ... develop their ideas into solutions, products and services ... university is recruiting participants for AREA48 (Applied Regional ... provides early-stage entrepreneurs with opportunities to access human ... anyone, ASU is particularly seeking participation from retirees, ...
(Date:5/21/2013)... 21, 2013 Phoseon Technology will present ... the 20th Annual IMI European Ink Jet Conference ... leader, Phoseon continues to invest in product development to ... of UV LED curing in printing applications. Phoseon ... the market offering both air cooled and water cooled ...
(Date:5/21/2013)... Modern couples have countless strains on ... Sexuality and Relationship Workshops, couples are learning the ... habits for their relationship. There are both private ... individuals at Texas Counseling. Their goal is to ... to develop long term solutions. , Developing ...
Breaking Medicine News(10 mins):Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2
... SAN ANTONIO, July 15 While some say that paying ... of Starbuck,s coffee is expensive, there,are many who are willing ... sales jumped 13% to $315.5 million. With Botox sales on ... economic recession or has,looking good become a necessity?, A ...
... Althea Technologies, Inc., a leading,provider of innovative ... announced today that E.J. Brandreth has,joined the ... Regulatory. In this,role, Mr. Brandreth will be ... while overseeing the regulatory support activities,which are ...
... and financial resources, including Social Security Disability Insurance benefits, when individuals ... ... IL (Vocus) July 15, 2008 -- Someone can become disabled in ... a gradual onset of chronic illness. Then the financial blow hits—the ...
... Straight teeth can improve your dental health, enhance your facial appearance and ... a huge difference in the quality of one's life. Both children and ... Orthodontic treatment can benefit social and career success as well as improve ... ...
... social and economic resources were more supportive in ... which in turn influenced the children,s cognitive performance. ... that considers how economic factors and parenting quality ... the Center for Research on Culture, Development, and ...
... A new vision screening device, already shown to give ... patients a head start on treating diabetes and its vision ... by two scientists at the University of Michigan Kellogg Eye ... and tissue damage that occur before the first symptoms of ...
Cached Medicine News:Health News:Kimberly Finder, M.D. Asks: Are We Really In an Economic Recession? 2Health News:Althea Technologies Appoints E.J. Brandreth to Vice President of Quality and Regulatory 2Health News:Key Steps Can Help with Financial Impact of Disability 2Health News:Key Steps Can Help with Financial Impact of Disability 3Health News:Key Steps Can Help with Financial Impact of Disability 4Health News:Ron Greenspan DDS Creates Plan to Eliminate the Barriers to Orthodontic Treatment 2Health News:Family resources, parenting quality influence children's early cognitive development 2Health News:'Snapshots' of eyes could serve as early warning of diabetes 2Health News:'Snapshots' of eyes could serve as early warning of diabetes 3
Single-Piece PMMA Intraocular Lenses....
Single Piece PMMA Lens (Refractive and Bifocal). Anterior chamber Lens....
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens....
STABIBAG Hydrophilic Acrylic Lens....
Medicine Products: